Literature DB >> 15858012

Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.

Stephanie A Campbell1, Jennifer Lin, Elena Y Dobrikova, Matthias Gromeier.   

Abstract

The ability of poliovirus to propagate in neuronal cells can be reduced by introducing appropriate nucleotide substitutions into the viral genome. Specific mutations scattered throughout the poliovirus genome yielded the live attenuated vaccine strains of poliovirus. Neuron-specific propagation deficits of the Sabin strains are partially encrypted within a confined region of the internal ribosomal entry site (IRES), which carries attenuating point mutations in all three serotypes. Recently, high levels of neurovirulence attenuation were achieved with genetically engineered polioviruses containing heterologous IRES elements. This is exemplified with poliovirus recombinants replicating under control of a human rhinovirus type 2 (HRV2) IRES element. We have carried out experiments delineating the genetic basis for neuronal IRES function. Neuronal dysfunction of the HRV2 IRES is determined mainly by IRES stem-loop domain V, the locus for attenuating point mutations within the Sabin strains. Neuronal incompetence associated with HRV2 IRES domain V is substantially more pronounced than that observed with the attenuating IRES point mutation of the Sabin serotype 1 vaccine strain. Mix-and-match recombination of polio and HRV2 IRES domain V suggests that the attenuation phenotype correlates with overall structural features rather than primary sequence. Our experiments have identified HEK 293 cells as a novel system for the study of neuron-specific replication phenotypes of poliovirus. This cell line, originally derived from embryonic human kidney, has recently been described to display neuronal characteristics. We report propagation properties in HEK 293 cells for poliovirus recombinants with attenuated neurovirulence in experimental animals that corroborate this observation.

Entities:  

Mesh:

Year:  2005        PMID: 15858012      PMCID: PMC1091735          DOI: 10.1128/JVI.79.10.6281-6290.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  5' cloverleaf in poliovirus RNA is a cis-acting replication element required for negative-strand synthesis.

Authors:  D J Barton; B J O'Donnell; J B Flanegan
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Cell-specific proteins regulate viral RNA translation and virus-induced disease.

Authors:  E V Pilipenko; E G Viktorova; S T Guest; V I Agol; R P Roos
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells.

Authors:  Gerry Shaw; Silas Morse; Miguel Ararat; Frank L Graham
Journal:  FASEB J       Date:  2002-04-10       Impact factor: 5.191

4.  Impaired binding of standard initiation factors mediates poliovirus translation attenuation.

Authors:  Kerstin Ochs; Amandus Zeller; Lanja Saleh; Gergis Bassili; Yutong Song; Anja Sonntag; Michael Niepmann
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Polypyrimidine-tract binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA.

Authors:  S L Hunt; R J Jackson
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

6.  Poly(A)-binding protein interaction with elF4G stimulates picornavirus IRES-dependent translation.

Authors:  Y V Svitkin; H Imataka; K Khaleghpour; A Kahvejian; H D Liebig; N Sonenberg
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

7.  The molecular basis of poliovirus neurovirulence.

Authors:  S Ohka; A Nomoto
Journal:  Dev Biol (Basel)       Date:  2001

8.  Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites.

Authors:  Andrew T Dufresne; Elena Y Dobrikova; Stacie Schmidt; Matthias Gromeier
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 9.  Class III beta-tubulin in human development and cancer.

Authors:  Christos D Katsetos; Mary M Herman; Sverre J Mörk
Journal:  Cell Motil Cytoskeleton       Date:  2003-06

10.  Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.

Authors:  Eugenia Dragunsky; Tatsuji Nomura; Kazimir Karpinski; John Furesz; David J Wood; Yuri Pervikov; Shinobu Abe; Takeshi Kurata; Olivier Vanloocke; Galina Karganova; Rolf Taffs; Alan Heath; Anna Ivshina; Inessa Levenbook
Journal:  Bull World Health Organ       Date:  2003-05-16       Impact factor: 9.408

View more
  35 in total

1.  MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus.

Authors:  Christian Goetz; Richard G Everson; Linda C Zhang; Matthias Gromeier
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

2.  Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements.

Authors:  Stephanie A Campbell; Matthew Mulvey; Ian Mohr; Matthias Gromeier
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Breaking pseudo-twofold symmetry in the poliovirus 3'-UTR Y-stem by restoring Watson-Crick base pairs.

Authors:  Jan Zoll; Marco Tessari; Frank J M Van Kuppeveld; Willem J G Melchers; Hans A Heus
Journal:  RNA       Date:  2007-05       Impact factor: 4.942

4.  Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD.

Authors:  Paola Florez de Sessions; Elena Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

Review 5.  Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

Authors:  Christian Goetz; Matthias Gromeier
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-17       Impact factor: 7.638

6.  Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements.

Authors:  Adriane Marschalek; Stefan Finke; Martin Schwemmle; Daniel Mayer; Bernd Heimrich; Lothar Stitz; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 7.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

8.  Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay.

Authors:  Xiaoyi Yang; Eying Chen; Hengguang Jiang; Karen Muszynski; Raymond D Harris; Steven L Giardina; Matthias Gromeier; Gautam Mitra; Gopalan Soman
Journal:  J Virol Methods       Date:  2008-11-08       Impact factor: 2.014

Review 9.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

10.  Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76.

Authors:  Melinda K Merrill; Elena Y Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.